Differences in nuclear retention characteristics of agonist-activated glucocorticoid receptor may determine specific responses

We studied the glucocorticoid response to the synthetic steroid pregna-1,4-diene-11β-ol-3,20-dione (ΔHOP) in several cell types and correlated its biological effect with the ability of the glucocorticoid receptor (GR) to be retained in the nuclear compartment. We observed that the ΔHOP-transformed G...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Vicent, G.P
Otros Autores: Pecci, A., Ghini, A., Piwien-Pilipuk, G., Galigniana, M.D
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: Elsevier 2002
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 15783caa a22013097a 4500
001 PAPER-5222
003 AR-BaUEN
005 20230518203451.0
008 190411s2002 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0036352904 
024 7 |2 cas  |a adenosine triphosphate, 15237-44-2, 56-65-5, 987-65-5; dexamethasone, 50-02-2; digitonin, 11024-24-1; mifepristone, 84371-65-3; molybdic acid, 11116-47-5, 14259-85-9, 7782-91-4 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a ECREA 
100 1 |a Vicent, G.P. 
245 1 0 |a Differences in nuclear retention characteristics of agonist-activated glucocorticoid receptor may determine specific responses 
260 |b Elsevier  |c 2002 
270 1 0 |m Galigniana, M.D.; 1301 Med. Sci. Research Building III, Department of Pharmacology, Univ. of Michigan Medical School, Ann Arbor, MI 48109, United States; email: mgali@umich.edu 
506 |2 openaire  |e Política editorial 
504 |a Galigniana, M.D., Scruggs, J.L., Herrington, M.J., Welsh, M.J., Carter-Su, C., Housley, P.R., Pratt, W.B., Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton (1998) Mol. Endocrinol., 12, pp. 903-1912 
504 |a Galigniana, M.D., Radanyi, C., Renoir, J.M., Housley, P.R., Pratt, W.B., Evidence that the peptidylprolyl isomerase (PPlase) domain of the hsp90-binding immunophilin FKBP52 is a dynein interaction domain involved in glucocorticoid receptor movement to the nucleus (2001) J. Biol. Chem., 276, pp. 14884-14889 
504 |a DeFranco, D.B., Qi, M., Borror, K.C., Garabedian, M.J., Brautigan, D.L., Protein-phosphatases type 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors (1991) Mol. Endocrinol., 5, pp. 1215-1228 
504 |a Piwien-Pilipuk, G., Galigniana, M.D., Tautomycin inhibits phosphatase-dependent transformation of the rat kidney mineralocorticoid receptor (1998) Mol. Cell. Endocrinol., 144, pp. 1903-1913 
504 |a Galigniana, M.D., Housley, P.R., DeFranco, D.B., Pratt, W.B., Inhibition of glucocorticoids receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton (1999) J. Biol. Chem., 274, pp. 16222-16227 
504 |a Pratt, W.B., Toft, D.O., Steroid receptor interactions with heat shock protein and immunophilin chaperones (1997) Endocr. Rev., 18, pp. 306-360 
504 |a Mader, S., Kumar, V., De Vemuil, H., Chambon, P., Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element (1989) Nature, 338, pp. 271-274 
504 |a Ruppert, S., Boshart, M., Bosch, F.X., Schmid, W., Fournier, R.E., Schütz, G., Two genetically defined transacting loci coordinately regulate overlapping sets of liver-specific genes (1990) Cell, 61, pp. 895-904 
504 |a Beato, M., Herrlich, P., Schültz, G., Steroid hormone receptors: Many actors in search of a plot (1995) Cell, 83, pp. 851-857 
504 |a Schüle, R., Rangarajan, P., Kliewer, S., Ransone, L.J., Bolado, J., Yang, N., Verma, I.M., Evans, R.M., Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor (1990) Cell, 62, pp. 1217-1226 
504 |a Diamond, M.I., Miner, J.N., Yoshinaga, S.K., Yamamoto, K.R., Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element (1990) Science, 249, pp. 1266-1272 
504 |a Stein, B., Baldwin, A.S.J., Ballard, D.W., Greene, W.C., Angel, P., Herrlich, P., Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function (1993) EMBO J., 12, pp. 3879-3891 
504 |a Imai, E., Stromstedt, P.-E., Quinn, P.G., Carlstedt-Duke, J., Gustafsson, J.-A., Granner, D., Characterization of a complex glucocorticoid response unit in the PEPCK gene (1990) Mol. Cell. Biol., 10, pp. 4712-4719 
504 |a Chang, T.J., Scher, B.M., Waxman, S., Scher, W., Inhibition of mouse GATA-1 function by the glucocorticoid receptor: Possible mechanism of steroid inhibition of erytroleukemia cell differentiation (1993) Mol. Endocrinol., 7, pp. 528-542 
504 |a Stocklin, E., Wissler, M., Gouilleux, F., Groner, B., Functional interactions between Stat-5 and the glucocorticoid receptor (1996) Nature, 383, pp. 726-728 
504 |a Franckhauser, S., Antras-Ferry, J., Robin, P., Robin, D., Granner, D., Forest, C., Expression of the phosphoenolpyruvate carboxykinase gene in 3T3-F442A adipose cells: Opposite effects of dexamethasone and isoprenaline on transcription (1995) Biochem. J., 305, pp. 65-71 
504 |a Guido, E.C., Delorme, E.O., Clemm, D.L., Stein, R.B., Rosen, J., Miner, J.N., Determinants of promoter-specific activity by glucocorticoid receptor (1996) Mol. Endocrinol., 10, pp. 1178-1190 
504 |a Ashwell, J.D., Lu, F.W.M., Vacchio, M.S., Glucocorticoids in T cell development and function (2000) Annu. Rev. Immunol., 18, pp. 309-345 
504 |a Reichardt, H.M., Kaestner, K.H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schültz, G., DNA binding of the glucocorticoid receptor is not essential for survival (1998) Cell, 93, pp. 531-541 
504 |a Reichardt, H.M., Tuckermann, J.P., Göttlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., Schültz, G., Repression of inflammatory responses in the absence of DNA binding by glucocorticoid receptor (2001) EMBO J., 20, pp. 7168-7173 
504 |a Zömig, M., Hueber, A.O., Braum, W., Evan, G., Apoptosis regulators and their role in tumorgenesis (2001) Biochem. Biophys. Acta, 1551, pp. F1-F37 
504 |a González, M.D., Burton, G., A carbon-13 nuclear magnetic resonance study of the 1,4-diene analogues of steroid hormones and related steroids (1984) Org. Magn. Reson., 22, pp. 586-591 
504 |a Vicent, G.P., Pecci, A., Ghini, A.A., Piwien-Pilipuk, G., Veleiro, A.S., Burton, G., Lantos, C.P., Galigniana, M.D., The glucocorticoid properties of the synthetic steroid pregna-1,4-diene-11β-ol-3,20-dione (ΔHOP) are not entirely correlated with the steroid binding to the glucocorticoid receptor (1999) Mol. Cell. Endocrinol., 149, pp. 207-219 
504 |a Vicent, G.P., Burton, G., Ghini, A.A., Lantos, C.P., Galigniana, M.D., Influence of calf serum on glucocorticoid-responses of certain progesterone derivatives (1998) J. Steroid Biochem. Mol. Biol., 66, pp. 211-216 
504 |a Rondinone, C.M., Schillaci, R., Roldán, A., Anti-inflamatory activity of 11β-hydroxypregna-1,4-diene-3,20-dione (1992) Drug Dev. Res., 26, pp. 61-65 
504 |a Rondinone, C.M., Schillaci, R., Lantos, C.P., Roldán, A., Appearance and persistence of 11β-hydroxypregna-1,4-diene-3,20-dione effect in vivo (1989) Acta Physiol. Pharmacol. Latinoam., 39, pp. 181-188 
504 |a Roldán, A., Burton, G., Castillo, M.B., Lantos, C.P., Inhibition of thymocyte RNA synthesis by natural adrenal steroids and their 1,4-diene analogs: Structure-activity correlations using 13C-NMR spectroscopy (1981) J. Steroid Biochem., 15, pp. 467-472 
504 |a Piwien-Pilipuk, G., Van Mater, D., Ross, S.E., MacDougald, O.A., Schwartz, J., Growth hormone regulates phosphorylation and function of CCAAT/Enhancer-binding protein β by modulating Akt and glycogen synthase kinase-3 (2001) J. Biol. Chem., 276, pp. 19664-19671 
504 |a Pecci, A., Scholz, A., Pelster, D., Beato, M., Progestins prevent apoptosis in a rat endometrial cell line and increase the ratio of bcl-XL to bcl-XS (1997) J. Biol. Chem., 272, pp. 11791-11798 
504 |a Galigniana, M.D., Vicent, G.P., Piwien-Pilipuk, G., Burton, G., Lantos, C.P., Mechansim of action of the potent sodium-retaining steroid 11,19-oxidoprogesterone (2000) Mol. Pharmacol., 58, pp. 58-70 
504 |a Gerschenson, L.E., Rotello, R.J., (1992) Apoptosis: The Molecular Bases of Cell Death, pp. 175-192. , L. D. Tomei and F. D. Cope, Eds., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 
504 |a Helftenbein, G., Alvarez, C.V., Tuohima, P., Beato, M., Expression of epithelial phenotype is enhanced by v-Haras in rat endometrial cells immortalized by SV40-T antigen (1993) Oncogene, 8, pp. 2075-2085 
504 |a Yang, J., Liu, J., DeFranco, D.B., Subnuclear trafficking of glucocorticoid receptors in vitro: Chromatin recycling and nuclear export (1997) J. Cell Biol., 137, pp. 523-538 
504 |a McNally, J.G., Müller, W.G., Walker, D., Wolford, R., Hager, G.L., The glucocorticoid receptor: Rapid exchange with regulatory sites in living cells (2000) Science, 287, pp. 1262-1265 
504 |a Hendzel, M.J., Kruhlak, M.J., MacLean, N.A.B., Boisvert, F.M., Lever, M.A., Bazett-Jones, D.P., Compartmentalization of regulatory proteins in the cell nucleus (2001) J. Steroid Biochem. Mol. Biol., 76, pp. 9-21 
504 |a Htun, H., Holth, L.T., Walker, D., Davie, J.R., Hager, G.L., Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor (1999) Mol. Biol. Cell, 10, pp. 471-486 
504 |a Fejes-Toth, G., Pearce, D., Naray-Fejes-Toth, A., Subcellular localization of mineralocorticoid receptors in living cells: Effects of receptor agonists and antagonists (1998) Proc. Natl. Acad. Sci. USA, 93, pp. 2973-2978 
504 |a Yeh, W.C., Cao, Z., Clason, M., McKnight, S.L., Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins (1995) Genes Dev., 9, pp. 168-181 
504 |a Liao, J., Piwien-Pilipuk, G., Ross, S.E., Hodge, C.L., Sealy, L., MacDougald, O.A., Schwartz, J., CCAAT/Enhancer-binding protein β (C/EBPβ) and C/EBPδ contribute to growth hormone-regulated transcription of c-fos (1999) J. Biol. Chem., 274, pp. 31597-31604 
504 |a Lawrence, J.B., Singer, R.H., McNeil, J.B., Interphase and metaphase resolution of different distances within the human dystrophin gene (1990) Science, 249, pp. 928-932 
504 |a Tumbar, T., Sudlow, G., Belmont, S.A., Large scale chromatin unfolding and remodeling induced by VP16 acidic activation domain (1999) J. Cell Biol., 145, pp. 1341-1354 
504 |a Cmarko, D., Verschure, P.J., Martin, T.E., Dahmus, M.E., Krause, S., Fu, X.D., Van Driel, R., Fakan, S., Ultrastructural analysis of transcription and splicing in the cell nucleus after bromo-UTP microinjection (1999) Mol. Biol. Cell, 10, pp. 211-223 
504 |a Fakan, S., Bemhard, W., Localisation of rapidly and slowly labelled nuclear RNA as visualized by high resolution autoradiography (1971) Exp. Cell Res., 67, pp. 129-141 
504 |a Iborra, F.J., Pombo, A., Jackson, D.A., Cook, P.R., Active RNA polymerases are localized within discrete transcription 'factories' in human nuclei (1996) J. Cell Sci., 109 (PART 6), pp. 1427-1436 
504 |a Wansink, D.G., Sibon, O.C., Cremers, F.F., Van Driel, R., De Jong, L., Ultrastructural localization of active genes in nuclei of A431 cells (1996) J. Cell. Biochem., 62, pp. 10-18 
504 |a Grande, M.A., Van der Kraan, I., De Jong, L., Van Driel, R., Nuclear distribution of transcription factors in relation to sites of transcription and RNA polymerase II (1997) J. Cell Biol., 110 (PART 15), pp. 1781-1791 
520 3 |a We studied the glucocorticoid response to the synthetic steroid pregna-1,4-diene-11β-ol-3,20-dione (ΔHOP) in several cell types and correlated its biological effect with the ability of the glucocorticoid receptor (GR) to be retained in the nuclear compartment. We observed that the ΔHOP-transformed GR was diffusely distributed in the nucleus compared to the discrete structures observed for the dexamethasone (DEX)-transformed GR. Despite the fact that the receptor was entirely nuclear upon binding of each steroid and exhibited identical nuclear export rates, a greater amount of ΔHOP-transformed GR was recovered in the cytoplasmic fraction after hypotonic cell lysis. Furthermore, accelerated nuclear export of GR was evidenced in digitonin-permeabilized cells treated with ATP and molybdate. Inasmuch as limited trypsinization of DEX-GR and ΔHOP-GR complexes yielded different proteolytic products, we conclude that GR undergoes a differential conformational change upon binding of each ligand. We propose that these conformational differences may consequently lead to changes of stability in the interaction of the GR with chromatin. Therefore, the dynamic exchange of liganded GR with chromatin is likely to have significant consequences for the observed pleiotropic physiological responses triggered by glucocorticoid ligands, not only in different tissues but also in the same cell type. © 2002 Elsevier Science (USA).  |l eng 
536 |a Detalles de la financiación: We thank Dr. M. Beato (Philipps Universität, Marburg, Germany) for providing the Rentro-1 cell line, Dr. H. Green (Harvard University) for providing the 3T3-F442A cell line (courtesy of Dr. J. Schwartz, University of Michigan), and Dr. W. B. Pratt (University of Michigan) for the kind gift of UP30 antibody. We are also indebted to Dr. G. Burton and Dr. C. P. Lantos (Universidad de Buenos Aires) for their critical and constructive comments. Part of this work was supported by grants from Fundación Antorchas and Ministerio de Salud Pública de la República Argentina to A.P. 
593 |a Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, 1428, Buenos Aires, Argentina 
593 |a Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, 1428, Buenos Aires, Argentina 
593 |a Department of Physiology, University of Michigan Medical School, Ann Arbor, Mi 48109, United States 
593 |a Department of Pharmacology, University of Michigan, Medical School, Ann Arbor, Mi 48109, United States 
690 1 0 |a ADENOSINE TRIPHOSPHATE 
690 1 0 |a DEXAMETHASONE 
690 1 0 |a DIGITONIN 
690 1 0 |a GLUCOCORTICOID RECEPTOR 
690 1 0 |a MIFEPRISTONE 
690 1 0 |a MOLYBDIC ACID 
690 1 0 |a PREGNA 1,4 11BETA OL 3,20 DIONE 
690 1 0 |a STEROID 
690 1 0 |a UNCLASSIFIED DRUG 
690 1 0 |a ANIMAL CELL 
690 1 0 |a ANIMAL TISSUE 
690 1 0 |a APOPTOSIS 
690 1 0 |a ARTICLE 
690 1 0 |a CELL MEMBRANE PERMEABILITY 
690 1 0 |a CELL PERMEABILIZATION 
690 1 0 |a CHROMATIN 
690 1 0 |a CONFORMATION 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a CYTOLYSIS 
690 1 0 |a DOSE RESPONSE 
690 1 0 |a DRUG EFFECT 
690 1 0 |a LIGAND BINDING 
690 1 0 |a MALE 
690 1 0 |a MOUSE 
690 1 0 |a NONHUMAN 
690 1 0 |a PLEIOTROPY 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROTEIN DEGRADATION 
690 1 0 |a RAT 
653 0 0 |a ru 486, Amersham, United States 
700 1 |a Pecci, A. 
700 1 |a Ghini, A. 
700 1 |a Piwien-Pilipuk, G. 
700 1 |a Galigniana, M.D. 
773 0 |d Elsevier, 2002  |g v. 276  |h pp. 142-154  |k n. 2  |p Exp. Cell Res.  |x 00144827  |w (AR-BaUEN)CENRE-797  |t Experimental Cell Research 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036352904&doi=10.1006%2fexcr.2002.5532&partnerID=40&md5=64c3031931de14fbfb1c588c9e856f7c  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1006/excr.2002.5532  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_00144827_v276_n2_p142_Vicent  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00144827_v276_n2_p142_Vicent  |y Registro en la Biblioteca Digital 
961 |a paper_00144827_v276_n2_p142_Vicent  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 66175